Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir

Clinical trial NCT03631316 · COMPLETED

Trial details

NCT number: NCT03631316
Sponsor: Luis Eduardo Morales Buenrostro
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Kidney Transplantation Cytomegalovirus Infections Pharmacokinetics Therapeutic Equivalency

Start date: 2018-03-01
Primary completion: 2018-10-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.